HuTao Health Technology Appointed Standing Committee Member of Medical Imaging Technology Committee, Driving Innovation with AI-Powered Imaging Solutions

At the inaugural meeting of the Medical Imaging Technology Professional Committee under the Chinese Medical Education Association, held recently, Hetao Technology attended as a core participant and was elected as a standing committee member unit, owing to its outstanding contributions to the medical imaging field and its leading achievements in artificial intelligence (AI) technology applications. This honorary position not only represents high recognition from the industry for Hetao Technology’s long-term commitment to advancing medical imaging technology, but also underscores strong endorsement of the significant effectiveness of its AI technologies in medical imaging applications.

Since its establishment in 2006, Walnut Technology has remained at the forefront of research and development in medical imaging technology. Over the past two decades, through strategic deployment and sustained efforts, the company has successfully developed a series of efficient and intelligent medical imaging solutions. Notably, its independent imaging assessment products have demonstrated exceptional performance in hospital-based clinical drug trials, fully showcasing their ability to leverage artificial intelligence for objective and accurate analysis of imaging data. This capability has significantly enhanced the efficiency of drug efficacy and safety studies, shortened clinical trial cycles, reduced R&D costs, and provided patients with safer and more effective treatment options.

HuTao Technology has also achieved a major breakthrough in the field of cardiovascular disease treatment with its intelligent management system for interventional procedures. By integrating multimodal imaging data, the system enables real-time monitoring of interventional surgeries and leverages artificial intelligence to provide precise decision support, significantly enhancing surgical accuracy and success rates. Particularly against the backdrop of an increasingly severe landscape in cardiovascular disease prevention and control, the launch of this system serves as a sharper “scalpel,” instilling confidence and hope in both physicians and patients.

Recognizing the critical importance of imaging data management in scientific research and clinical trials for ensuring quality and progress, Walnut Technology has leveraged advanced artificial intelligence to establish a comprehensive data management system. This system ensures standardized operations across all stages—from data acquisition, storage, processing, and classification to sharing—thereby setting new industry standards for data management.

Looking ahead, Hutu Technology will uphold its mission of “technology serving people,” continue to deepen the application of artificial intelligence in medical imaging, and consistently introduce more innovative and efficient solutions. The company firmly believes that, driven by the powerful momentum of AI technology, medical imaging will usher in unprecedented opportunities for growth, making greater contributions to human health. Meanwhile, Hutu Technology will collaborate with industry partners to jointly advance innovation and development in medical imaging, opening a new chapter for the sector.